Biopharmaceutical
BIOETHICS
Move Values to Action
Make Bioethics an Everyday Practice by Going Beyond Compliance
MISSION. VISION. VALUES.
These are the Northstars for every organization. But, how do you make core values come alive?
Knowing how to effectively, efficiently, and consistently promote values within the complex biopharmaceutical industry can be challenging, especially without clear ethical standards.
Often the distinction between ethics and compliance is blurred, resulting in an over-reliance on regulatory requirements to address ethical concerns – and more specifically – bioethical concerns.
At EthicsMatters LLC (EthicsMatters), we are on a mission to move values to ethical action by equipping organizational leaders to use an intentional, systematic approach to bioethics.
A NEW LENS IS NEEDED
A NEW LENS IS NEEDED
Our proprietary Values-to-Action System™ ensures bioethics is embedded within daily operations and decisions -- helping employees view their work through a bioethics lens.
This System and associated processes are the framework for our consulting and training services.
Click on the box below to see how we can help your organization.
OUR GOAL
To move values to action by enhancing the process of bioethical inquiry and empowering leaders to innovate with integrity.
Although other advisors can provide expert input on specific bioethics issues, EthicsMatters is uniquely positioned to provide advice on both bioethics and organizational ethics issues.
Dr. Luann E. Van Campen, Founder and President of EthicsMatters has extensive experience integrating bioethics into a biopharmaceutical corporate environment, giving her a distinctive perspective. She’s been in your shoes and speaks your language.
Luann E.Van Campen
PhD, MA-Bioethics
EthicsMatters is the brainchild of Dr. Luann Van Campen, a recognized leader in biopharmaceutical bioethics.
Dr. Van Campen was Eli Lilly and Company’s first full-time bioethicist and one of the first in the industry to hold such a role. During her 10 years as Senior Advisor and Head of Bioethics, she and her team conducted nearly 400 consultation cases, developed 16 company positions, and created a bioethics framework for human biomedical research.
Her innovative efforts earned her Lilly’s
“They’re Making a Difference” recognition.
“Dr. Van Campen has been an invited lecturer in my course on Regulatory Science taught at the University of Michigan. She has been involved in this course for many years and regularly gets stellar reviews for her presentations and her insights. Great speaker with tremendous knowledge in the ethics field.”
Frank J. Ascione, PharmD, PhD
Professor and Former Dean, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
